Capricorn Fund Managers Ltd Acquires Shares of 19,404,192 The Beauty Health Company $SKIN

Capricorn Fund Managers Ltd bought a new stake in The Beauty Health Company (NASDAQ:SKIN) during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 19,404,192 shares of the company’s stock, valued at approximately $17,270,000. Beauty Health makes up approximately 2.7% of Capricorn Fund Managers Ltd’s investment portfolio, making the stock its 10th largest holding. Capricorn Fund Managers Ltd owned about 0.15% of Beauty Health as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in SKIN. Mirabella Financial Services LLP increased its position in shares of Beauty Health by 21.3% during the 3rd quarter. Mirabella Financial Services LLP now owns 15,596,277 shares of the company’s stock worth $31,037,000 after purchasing an additional 2,734,728 shares in the last quarter. HRT Financial LP acquired a new position in Beauty Health in the fourth quarter valued at about $47,000. AQR Capital Management LLC acquired a new position in Beauty Health in the first quarter valued at about $40,000. Ameriprise Financial Inc. bought a new stake in Beauty Health during the third quarter worth about $38,000. Finally, Zacks Investment Management bought a new stake in Beauty Health during the third quarter worth about $35,000. Institutional investors own 93.26% of the company’s stock.

Beauty Health Stock Down 2.8%

Shares of NASDAQ:SKIN opened at $0.69 on Wednesday. The company has a quick ratio of 1.48, a current ratio of 1.79 and a debt-to-equity ratio of 4.37. The firm has a market cap of $89.75 million, a P/E ratio of -4.07 and a beta of 1.09. The Beauty Health Company has a 12 month low of $0.55 and a 12 month high of $2.69. The company’s 50-day moving average price is $0.72 and its two-hundred day moving average price is $1.05.

Beauty Health (NASDAQ:SKIN) last announced its earnings results on Thursday, May 7th. The company reported ($0.05) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.09) by $0.04. Beauty Health had a negative net margin of 2.03% and a negative return on equity of 9.38%. The company had revenue of $64.91 million during the quarter, compared to the consensus estimate of $66.28 million. As a group, research analysts forecast that The Beauty Health Company will post -0.14 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on SKIN shares. Zacks Research upgraded shares of Beauty Health from a “strong sell” rating to a “hold” rating in a research note on Monday, March 16th. TD Cowen decreased their price target on Beauty Health from $1.65 to $1.50 and set a “hold” rating on the stock in a research report on Monday, March 16th. Benchmark reaffirmed a “hold” rating on shares of Beauty Health in a report on Friday, March 13th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Beauty Health in a report on Wednesday, June 24th. Finally, Roth Mkm reiterated a “buy” rating and issued a $2.00 price objective (down from $2.50) on shares of Beauty Health in a research report on Wednesday, May 20th. One investment analyst has rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $2.02.

Beauty Health Company Profile

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.